Product Lines > Cancer Research > Epigenetic Inhibitors

Epigenetic Inhibitors

Epigenetic events, such as DNA methylation and covalent modification of histones, have been demonstrated to silence the expression of many genes that suppress malignancy. Since the event is reversible, it is an interesting target for intervention with specific inhibitors of DNA methylation and histone deacetylation.

InvivoGen provides two such inhibitors:
- 5-AzadCyd, inhibitor of DNA methyltransferases (DNMTs)
- Trichostatin A, inhibitor of histone deacetylases (HDACs)

Both inhibitors have been demonstrated to be promising anticancer agents used either separately or in combination.

5-AzadCyd

Show All | Hide All
Description
Formula
Contents and Storage

ProductTDS MSDSQtyCat.
Code
Order 
5-AzadCydPDFPDF10 mg met-adc-1 cart
5-AzadCydPDFPDF50 mg met-adc-5 cart

Trichostatin A

Show All | Hide All
Description
Formula
Contents and Storage

ProductTDS MSDSQtyCat.
Code
Order 
Trichostatin APDFPDF1 mg met-tsa-1 cart
Trichostatin APDFPDF5 mg met-tsa-5 cart


Disclaimer: Our products are provided for research purpose only. Commercial applications may require licensing from third parties.
Note that the sequence of available ORFs provided by InvivoGen can differ from a given reference Genbank record due to genetic variations and/or alternative splicing. Customers should verify that the version of a gene sold by InvivoGen is suitable for the customer needs.

Copyrights © 2010 InvivoGen. All Rights Reserved. Reproduction of any materials from this site is strictly forbidden without permission for commercial use. Nonprofit use for non-commercial research and educational purposes is permitted, citation should include the URL "www.invivogen.com".